Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0M1PL
|
|||
| Former ID |
DIB012019
|
|||
| Drug Name |
Gadoteridol
|
|||
| Synonyms |
ProHance; SQ-32692; GD-HP-DO 3A; Gadolinium-HP-D03A
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Brain disease [ICD-11: 8C70-8E61; ICD-10: G00-G99] | Approved | [1], [2] | |
| Company |
Bayer Schering Pharma AG
|
|||
| Structure |
 |
Download2D MOL
|
||
| Formula |
C17H29GdN4O7
|
|||
| Canonical SMILES |
CC(CN1CCN(CCN(CCN(CC1)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])O.[Gd+3]
|
|||
| InChI |
1S/C17H32N4O7.Gd/c1-14(22)10-18-2-4-19(11-15(23)24)6-8-21(13-17(27)28)9-7-20(5-3-18)12-16(25)26;/h14,22H,2-13H2,1H3,(H,23,24)(H,25,26)(H,27,28);/q;+3/p-3
|
|||
| InChIKey |
DPNNNPAKRZOSMO-UHFFFAOYSA-K
|
|||
| CAS Number |
CAS 120066-54-8
|
|||
| PubChem Compound ID | ||||
| ADReCS Drug ID | BADD_D00993 | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
| REF 2 | ClinicalTrials.gov (NCT01613417) Comparison of Prohance With Gadovist/Gadavist in Magnetic Resonance Imaging (MRI) of the Brain. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.